Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
Original Article
M. Scully, S.R. Cataland, F. Peyvandi, P. Coppo, P. Knöbl, J.A.K. Hovinga, A. Metjian, J.d.l. Rubia, K. Pavenski, F. Callewaert, D. Biswas, H.D. Winter, and R.K. Zeldin
N Engl J Med 2019;380:335-346
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, January 24, 2021 - 11:59pm.